Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
Globe Newswire (Thu, 13-Aug 4:00 PM ET)
Assembly Biosciences Announces Upcoming Investor Conference Presentations
Globe Newswire (Thu, 28-May 4:05 PM ET)
Market Chameleon (Fri, 20-Mar 5:59 AM ET)
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Assembly Biosciences trades on the NASDAQ stock market under the symbol ASMB.
As of August 28, 2026, ASMB stock price declined to $34.07 with 248,025 million shares trading.
ASMB has a beta of 0.36, meaning it tends to be less sensitive to market movements. ASMB has a correlation of 0.01 to the broad based SPY ETF.
ASMB has a market cap of $693.69 million. This is considered a Small Cap stock.
Last quarter Assembly Biosciences reported $13 million in Revenue and -$.20 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.36.
In the last 3 years, ASMB traded as high as $39.71 and as low as $7.69.
The top ETF exchange traded funds that ASMB belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
ASMB has outperformed the market in the last year with a price return of +31.6% while the SPY ETF gained +20.1%. ASMB has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +24.3% and +13.8%, respectively, while the SPY returned +2.8% and -1.1%, respectively.
ASMB support price is $33.52 and resistance is $36.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASMB shares will trade within this expected range on the day.